DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Aclidinium bromide

Aclidinium bromide

  • Reference List of Drugs with Potential Anticholinergic Effects 1, 2, 3, 4, 5

    Reference List of Drugs with Potential Anticholinergic Effects 1, 2, 3, 4, 5

  • COPD Agents Review – October 2020 Page 2 | Proprietary Information

    COPD Agents Review – October 2020 Page 2 | Proprietary Information

  • FDA Briefing Document Pulmonary-Allergy Drugs Advisory Committee Meeting

    FDA Briefing Document Pulmonary-Allergy Drugs Advisory Committee Meeting

  • Drug Tariff Part VIIIA December 2019

    Drug Tariff Part VIIIA December 2019

  • Cdr Clinical Review Report for Incruse Ellipta

    Cdr Clinical Review Report for Incruse Ellipta

  • (Lamas) a New Frontier for COPD and Asthma Treatment

    (Lamas) a New Frontier for COPD and Asthma Treatment

  • Pipelinetr Ends

    Pipelinetr Ends

  • Profile of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease

    Profile of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease

  • PRAC Draft Agenda of Meeting 11-14 May 2020

    PRAC Draft Agenda of Meeting 11-14 May 2020

  • Medicines Formulary

    Medicines Formulary

  • Eklira Genuair, INN-Aclidinium Bromide

    Eklira Genuair, INN-Aclidinium Bromide

  • June 2021: Additions and Deletions to the Drug Product List

    June 2021: Additions and Deletions to the Drug Product List

  • Quick Reference Formulary

    Quick Reference Formulary

  • CDR Pharmacoeconomic Review Report for Trelegy Ellipta

    CDR Pharmacoeconomic Review Report for Trelegy Ellipta

  • Catch Your Breath Updates in Asthma and COPD Pharmacotherapy

    Catch Your Breath Updates in Asthma and COPD Pharmacotherapy

  • (Medicare-Medicaid Plan) Formulary Maintenance Drug List

    (Medicare-Medicaid Plan) Formulary Maintenance Drug List

  • Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile

    Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile

  • Doxepin > Printer-Friendly PDF

    Doxepin > Printer-Friendly PDF

Top View
  • Appendix B - Product Name Sorted by Applicant
  • IEHP Medi-Cal Formulary Maintenance Drug List
  • Doxepin > Printer-Friendly PDF
  • Comparative Efficacy of Aclidinium Versus Glycopyrronium And
  • Bretaris Genuair, INN-Aclidinium Bromide
  • Texas Medicaid Vendor Drug Program Drug Utilization Review Board
  • Inhaled Anticholinergics
  • Brand Generic Guide
  • Patient-Reported Outcomes and Considerations in the Management of COPD: Focus on Aclidinium
  • Vivo Profile of Aclidinium Bromide in Comparison With
  • Chronic Obstructive Pulmonary Disease: Glycopyrronium Bromide
  • Drug Development for Asthma and COPD: a Regulatory Perspective
  • FEP 5 Tier Rx Drug Formulary (607) Standard Option
  • Interactions with Experimental COVID-19 Therapies
  • PDL)/Non-Preferred Drug List (NPDL
  • Justification
  • DOWNLOAD INKE Apis PRODUCT LIST
  • Drug Formulary New York State Workers’ Compensation Effective August 7, 2019


© 2024 Docslib.org    Feedback